Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
SLB, DXCM, CRH: The Economy is Relatively Healthy
02:22pm, Thursday, 11'th Apr 2024
Economic trends and earnings continue to drive most of the conversations, notes Tyler Ellegard. He discusses the impact upcoming earnings could have on the markets.
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?
10:46am, Thursday, 11'th Apr 2024
Here is how DexCom (DXCM) and Anika Therapeutics (ANIK) have performed compared to their sector so far this year.
DexCom Is Pricey For A Reason - Its Growth Story Reflects That
09:02am, Thursday, 11'th Apr 2024
DexCom received FDA approval for its continuous glucose monitoring product, Stelo, to be available over the counter, making it the first OTC CGM product ever. The company has demonstrated robust growt
Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In
04:00pm, Wednesday, 10'th Apr 2024
The latest employment figures saw indices rise. However, losses earlier in the week persist as investors remain cautious of the Fed's stance on interest rate adjustments.
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
09:27am, Wednesday, 10'th Apr 2024
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Why the Market Dipped But DexCom (DXCM) Gained Today
07:06pm, Monday, 08'th Apr 2024
In the most recent trading session, DexCom (DXCM) closed at $139.94, indicating a +0.73% shift from the previous trading day.
DexCom, Inc. (DXCM) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 04'th Apr 2024
DexCom (DXCM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
7 Nasdaq Stocks to Sell in April Before They Crash & Burn
09:14am, Wednesday, 03'rd Apr 2024
The Nasdaq is absolutely on fire. The broad macroeconomic picture has been about as good as it could get for growth stocks.
DexCom (DXCM) Falls More Steeply Than Broader Market: What Investors Need to Know
07:05pm, Tuesday, 02'nd Apr 2024
In the closing of the recent trading day, DexCom (DXCM) stood at $136.65, denoting a -0.94% change from the preceding trading day.
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
08:30am, Tuesday, 02'nd Apr 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will
DexCom Stock Gains from GLP-1 Diabetic Users
07:17am, Tuesday, 02'nd Apr 2024
DexCom Inc. NASDAQ: DXCM is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to monitor thei
3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy' List
04:48pm, Monday, 01'st Apr 2024
BNN Bloomberg reported in July 2023 that the S&P 500 was overvalued by about 8%, according to Cresset Capital Chief Information Officer Jack Ablin. In the eight months since, it's up another 19%, prov
DexCom (DXCM) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Friday, 29'th Mar 2024
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
International Companies Drive Diabesity Innovation
09:59am, Friday, 29'th Mar 2024
International Companies Drive Diabesity Innovation
DexCom (DXCM) Hits 52-Week High: What's Driving the Stock?
12:01pm, Wednesday, 27'th Mar 2024
Investors are optimistic about DexCom's (DXCM) strong product portfolio.
